Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Izotropic Africa is a medical technology company focused on the commercialization of the IzoView Breast CT Imaging System within the African market. The company operates as a regional arm of the Canadian-based Izotropic Corporation, leveraging its proprietary 3D breast imaging technology to improve the detection and diagnosis of breast cancer. Unlike traditional mammography, the IzoView system provides high-resolution images without the need for painful breast compression, offering a more comfortable and accurate diagnostic experience. The technology utilizes cone-beam computed tomography to produce true 3D images, allowing for better visualization of dense breast tissue. Izotropic Africa aims to address the growing need for advanced oncological screening tools in emerging markets through strategic partnerships and local distribution networks. By introducing this next-generation imaging solution, the company seeks to enhance women's healthcare outcomes and early cancer detection across the continent.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Izotropic Africa.